Early research (Phase 1)Study completedNCT02938507
What this trial is testing
Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects
Who this might be right for
Healthy Subjects, Overactive Bladder
Velicept Therapeutics, Inc. 24